NAMI Presses CMS to Ensure that Atypical Antipsychotics are Included in the Upcoming Medicare Part B Competitive Acquisition Program (CAP)
August 4, 2005
Earlier this year, NAMI pushed the Centers for Medicare and Medicaid Services (CMS) to include atypical antipsychotic medications in the Part B CAP program covering non-self-injectible medications administered in physician offices and clinics. In July, CMS issued rules clarifying that antipsychotic medications will be included in the program. NAMI's letter to CMS is posted below.